Madrigal Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
20:55:01 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 440.50 EUR | -0.97% |
|
+0.85% | -11.05% |
| Market Cap | 11.94B 10.23B 9.57B 8.76B 16.44B 1,142B 16.66B 113B 44.09B 574B 44.83B 43.85B 1,898B | P/E 2026 * |
-81.8x | P/E 2027 * | 82.1x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41B 9.78B 9.15B 8.37B 15.72B 1,092B 15.92B 108B 42.15B 549B 42.86B 41.93B 1,815B | EV / Sales 2026 * |
7.48x | EV / Sales 2027 * | 5.13x |
| Free-Float |
94.13% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -0.97% | ||
| 1 week | +0.85% | ||
| Current month | +9.22% | ||
| 1 month | -7.83% | ||
| 3 months | -0.16% | ||
| 6 months | +19.60% | ||
| Current year | -11.05% |
| 1 week | 433.6 |  | 462.2 |
| 1 month | 398.8 | | 489 |
| Current year | 354 | | 506.4 |
| 1 year | 347.5 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 8.08 | | 523.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 07/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 10/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 20/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 30/06/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 10/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 26/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | +0.85% | - | - | 11.94B | |
| -3.00% | +2.27% | +77.60% | +109.33% | 72.12B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 65.85B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 29.28B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.47B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 26.7B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 20.06B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 18.22B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.4B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.4B | |
| Average | +1.03% | +8.36% | +59.94% | +196.82% | 32.17B | |
| Weighted average by Cap. | +0.67% | +9.48% | +59.05% | +157.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.53B 1.31B 1.22B 1.12B 2.1B 146B 2.13B 14.45B 5.64B 73.36B 5.73B 5.61B 243B | 2.14B 1.84B 1.72B 1.57B 2.95B 205B 2.99B 20.31B 7.92B 103B 8.05B 7.88B 341B |
| Net income | -184M -158M -147M -135M -253M -17.59B -257M -1.74B -679M -8.84B -690M -675M -29.23B | 200M 171M 160M 147M 275M 19.14B 279M 1.89B 739M 9.61B 751M 735M 31.79B |
| Net Debt | -525M -449M -420M -385M -722M -50.19B -732M -4.97B -1.94B -25.21B -1.97B -1.93B -83.39B | -943M -808M -756M -692M -1.3B -90.25B -1.32B -8.93B -3.48B -45.34B -3.54B -3.46B -150B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | €440.50 | -0.97% | 0 |
| 20/08/26 | €444.80 | -3.76% | 0 |
| 19/08/26 | €462.20 | +1.76% | 10 |
| 18/08/26 | €454.20 | +0.07% | 0 |
| 17/08/26 | €453.90 | +3.91% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Select your edition
All financial news and data tailored to specific country editions
